CN101053679A - Method for preparing polymer multiporous holder filled with fiber protein gel - Google Patents
Method for preparing polymer multiporous holder filled with fiber protein gel Download PDFInfo
- Publication number
- CN101053679A CN101053679A CN 200710068119 CN200710068119A CN101053679A CN 101053679 A CN101053679 A CN 101053679A CN 200710068119 CN200710068119 CN 200710068119 CN 200710068119 A CN200710068119 A CN 200710068119A CN 101053679 A CN101053679 A CN 101053679A
- Authority
- CN
- China
- Prior art keywords
- multihole
- fibrin gel
- fibrinogen
- polymer
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims abstract description 19
- 101710145505 Fiber protein Proteins 0.000 title 1
- 102000009123 Fibrin Human genes 0.000 claims abstract description 34
- 108010073385 Fibrin Proteins 0.000 claims abstract description 34
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims abstract description 34
- 229950003499 fibrin Drugs 0.000 claims abstract description 34
- 108010049003 Fibrinogen Proteins 0.000 claims abstract description 30
- 102000008946 Fibrinogen Human genes 0.000 claims abstract description 30
- 229940012952 fibrinogen Drugs 0.000 claims abstract description 30
- 108090000190 Thrombin Proteins 0.000 claims abstract description 21
- 229960004072 thrombin Drugs 0.000 claims abstract description 21
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 23
- 239000004626 polylactic acid Substances 0.000 claims description 23
- 102000008186 Collagen Human genes 0.000 claims description 8
- 108010035532 Collagen Proteins 0.000 claims description 8
- 229920001436 collagen Polymers 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 230000008676 import Effects 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 210000001612 chondrocyte Anatomy 0.000 abstract description 35
- 230000008439 repair process Effects 0.000 abstract description 7
- 230000012010 growth Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 230000004069 differentiation Effects 0.000 abstract description 3
- 230000005012 migration Effects 0.000 abstract description 3
- 238000013508 migration Methods 0.000 abstract description 3
- 239000002131 composite material Substances 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 abstract 3
- 238000009395 breeding Methods 0.000 abstract 1
- 230000001488 breeding effect Effects 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 239000002504 physiological saline solution Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 32
- 210000000845 cartilage Anatomy 0.000 description 18
- 238000011049 filling Methods 0.000 description 17
- 210000001519 tissue Anatomy 0.000 description 9
- 102000055008 Matrilin Proteins Human genes 0.000 description 6
- 108010072582 Matrilin Proteins Proteins 0.000 description 6
- 210000001188 articular cartilage Anatomy 0.000 description 6
- 230000006378 damage Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 239000000017 hydrogel Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 3
- 206010007710 Cartilage injury Diseases 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 241001484259 Lacuna Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 210000001162 elastic cartilage Anatomy 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 230000001723 fibrinogenic effect Effects 0.000 description 2
- 210000003035 hyaline cartilage Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 208000025978 Athletic injury Diseases 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 102000002734 Collagen Type VI Human genes 0.000 description 1
- 108010043741 Collagen Type VI Proteins 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000012771 pancakes Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
The invention discloses a preparation method of polymer multihole bracket filled with fibrin gel. The process is dissolving fibrinogen powder in physiological saline to prepare fibrinogen solution; dissolving thrombin in calcium chloride solution to prepare thrombin calcium chloride solution; injecting isovolumetric fibrinogen solution and thrombin solution into polymer multihole bracket to get polymer multihole bracket filled with fibrin gel. The polymer multihole bracket filled with fibrin gel of this invention have composite structural feature, wherein polymer multihole bracket provide a certain mechanical strength and space for chondrocyte growth, fibrin gel boosts migration, breeding and differentiation of chondrocyte, accelerates repair of chondrocyte, has very strong application value of repairing organise defect. The preparation method of this invention is simple and has wide material source, high production efficiency.
Description
Technical field
The present invention relates to a kind of preparation method of tissue regeneration support, especially the preparation method of polymer multihole bracket filled with fibrin gel.
Background technology
The cartilage injury is present common disease, because arthritis or articular cartilage damage that athletic injury caused bring misery for many patients.The metabolism of cartilage is active and repair ability is limited, does not have blood vessel, can not form the fiber grumeleuse after damage, does not have the inflammatory cell migration to enter, and does not also have the blood vessel undifferentiated cell to enter the position of damage, so difficultly repair voluntarily.In addition, this lacks undifferentiated cell in damage location cartilage, does not have the chondrocyte migration to grow among the cartilage of damage after the damage.And with advancing age, the splitting ability of chondrocyte reduces gradually, and the ability that produces extracellular matrix also decreases.Up to now, still lack effective method clinically and repair impaired cartilaginous tissue.Using the method for regenerative medicine and the reparation that principle is carried out cartilaginous tissue is a present important means, and has obtained good effect.Wherein, the repair of cartilage support plays crucial effect in regenerating bone or cartilage.
The cartilage of human body belongs to connective tissue, wherein contains a spot of chondrocyte and a large amount of intercellular substance.Chondrocyte is dispersed in the cartilage lacuna in cartilage matrix, and the substrate dyeing around the lacuna is called cartilage capsule more deeply.Inmature chondrocyte is less, and the normal single marginal zone that is distributed in articular cartilage is oblate.Increased gradually by the volume of edge to central chondrocyte, ovalize or circle have significantly cartilage capsule.Immature chondrocyte can divide, and normal 2～8 of deep mature chondrocytes distributes in groups.The chemical constituent of matter mainly comprises collagen protein, proteoglycan and a spot of noncollagen protein between chondrocyte.Collagen in the cartilaginous tissue is mainly the II Collagen Type VI, accounts for more than 90% of collagen total amount.The II type collagen fiber is three-dimensional netted distribution in cartilage, for articular cartilage provides tensile strength.Proteoglycan combines the huge proteoglycan aggregate of formation by connecting albumen with the non-covalent bond form with hyaluronic acid.Contain abundant negative acid ion on the proteoglycan aggregate strand, can form hydrogel in conjunction with a large amount of water, for cartilage provides comprcssive strength and elasticity.75% of water accounts cartilaginous tissue full weight wherein contains a large amount of cations with the negative charge in the balance proteoglycan molecule, and contains required nutrient substance of many chondrocytes and products of cellular metabolism.No blood vessel in the cartilaginous tissue, but because cartilage matrix is rich in moisture, nutrient substance is easy to infiltration, so chondrocyte still can obtain necessary nutrition.
Other noncollagen protein in the cartilaginous tissue such as anchor albumen, fiber adhesion albumen etc. by and cell surface receptor and other macromole between interaction chondrocyte is sticked on the cartilage matrix and the structure of stable cartilage matrix.
Different according to cartilage matrix composition and organizational structure, cartilage is divided into hyaline cartilage, fibrous cartilage and elastic cartilage.Articular cartilage belongs to hyaline cartilage, and its feature is that fiber content lacks than fibrous cartilage and elastic cartilage, and proteoglycan hydrogel content is more relatively, and cartilage matrix is a transparence.Sophisticated articular cartilage can be divided into shallow top layer, middle level, deep layer and calcification layer according to the variation of its cell and substrate.Wherein the proteoglycan content in middle level and the deep layer is higher.
The intravital cartilage of people has extremely special mechanical property.For example articular cartilage has good elasticity and toughness, can bear bigger load, has slick surface simultaneously, and the frictional force when making joint motion is minimum.Cartilaginous tissue is in a single day damaged, will bring huge misery and inconvenient to the patient.
In normal cartilage, surround by a large amount of collagens and proteoglycan extracellular matrix that form, high moisture high-crosslinking-degree around the mature chondrocytes, chondrocyte is spherical in shape.Yet when chondrocyte was cultured on the porous polymer scaffold, chondrocyte was pancake and sticks on the support hole wall.The unusual growing environment that studies show that in the past is disadvantageous for the normal differentiation and the phenotype of chondrocyte.On the other hand, chondrocyte can be kept normal sphere in hydrogel material, keeps normal chondrocyte phenotype simultaneously.But the mechanical strength of hydrogel is generally not high, in cultivation and the implant surgery, is very easy to because of stressed and damaged or cracked in vivo and in vitro.Therefore, in the design of repair of cartilage material, should simulate the spontaneous growth environment of chondrocyte, structure has the recovery support that can promote chondrocyte normal growth and functional expression.
Summary of the invention
The purpose of this invention is to provide a kind of preparation method that can simulate the polymer multihole bracket filled with fibrin gel of human body natural cartilage.
The preparation method of polymer multihole bracket filled with fibrin gel of the present invention may further comprise the steps:
1) fibrinogen powder is dissolved in the normal saline, compound concentration is the fibrinogen solution of 10～40mg/ml; Thrombin is dissolved in the calcium chloride solution, and compound concentration is the thrombin calcium chloride solution of 1～20U/ml;
2) porous polymer scaffold is immersed in the ethanol, adopts first evacuation, the method for pressure is recovered in the back, and ethanol is imported in the porous polymer scaffold; To import alcoholic acid support and be immersed in the tri-distilled water, and carry out first evacuation repeatedly, the method for pressure is recovered in the back, and ethanol is replaced as water, and is residual until no ethanol;
3) solution with isopyknic fibrinogen solution and thrombin is injected in the porous polymer scaffold simultaneously, to prop up to be placed in 37 ℃ of constant temperature ovens and hatch 5～10 minutes, make the complete gel of Fibrinogen, promptly obtain polymer multihole bracket filled with fibrin gel.
Among the present invention, said porous polymer scaffold can be polylactic acid, polylactic-co-glycolic acid, polyurethane or collagen porous support.
Beneficial effect of the present invention is:
The polymer multihole bracket filled with fibrin gel of the present invention's preparation has the composite construction feature, wherein porous polymer scaffold can provide the certain mechanical strength and the space of chondrocyte growth, and fibrin gel is the goods that derive from blood, have excellent biological compatibility and degradation property, wherein contain a large amount of active factorses, have migration, propagation and the differentiation performance of better promotion chondrocyte, quicken the reparation of cartilaginous tissue.Therefore, this compound system has the damaged using value of very strong repair tissue.Preparation method of the present invention is simple, material source is extensive, production efficiency is high.
Description of drawings
Fig. 1 is the laser confocal microscope photo of fibrin gel filling polylactic acid porous support, wherein fibrin gel fluorescent staining;
Fig. 2 is the fibrinogenic gelation curve of variable concentrations;
Fig. 3 is the filling rate of the Fibrinogen filling polylactic acid support of variable concentrations;
Fig. 4 is the mechanical property of pure polylactic acid porous scaffold and fibrin gel filling bracket;
Fig. 5 is the activity of chondrocyte in the fibrin gel filling bracket;
Fig. 6 is the secretion of the GAG of chondrocyte in fibrin gel filling polylactic acid support;
Fig. 7 is distribution and the form (week) of laser confocal microscope observation chondrocyte in fibrin gel filling polylactic acid support, and wherein cell adopts the method for fluorescein(e) diacetate to dye;
Fig. 8 is distribution and the form (week) of scanning electron microscope observation chondrocyte in fibrin gel filling polylactic acid support.
Specific implementation method
Further specify the present invention below in conjunction with example, but these examples are not used for limiting the present invention.
Example 1:
1) fibrinogen powder is dissolved in the normal saline, hatched 10 minutes in 37 ℃ of waters bath with thermostatic control, Fibrinogen is fully dissolved, the concentration of fibrinogen solution is 10mg/ml; Thrombin is dissolved in the 40mM calcium chloride solution, puts into 37 ℃ of waters bath with thermostatic control and hatched 10 minutes, be mixed with the solution of 1U/ml;
2) polylactic acid porous scaffold is immersed in the ethanol, adopts first evacuation, the method for pressure is recovered in the back, and ethanol is imported in the porous polymer scaffold, fully is immersed in the ethanol up to support; To import alcoholic acid support and be immersed in the tri-distilled water, and adopt first evacuation, the method for pressure is recovered in the back, and ethanol is replaced as water, replaces repeatedly 10 times, and is each 10 minutes, residual to there not being ethanol;
3) isopyknic fibrinogen solution and the thrombin solution with the step 1) preparation is injected in the polylactic acid porous scaffold simultaneously, to prop up to be placed in 37 ℃ of constant temperature ovens and hatch 10 minutes, make the complete gel of Fibrinogen, promptly obtain the polylactic acid porous scaffold that fibrin gel is filled.Fig. 1 is seen in the distribution of gel in polylactic acid bracket.
Example 2:
1) prepare Fibrinogen and thrombin solution with the method for example 1 step 1), but the concentration of fibrinogen solution is 40mg/ml.
Step 2) and 3) with the step 2 of example 1) and 3), the fibrin gel polylactic acid porous scaffold of filling.
Example 3:
1) prepares Fibrinogen and thrombin solution with the method for example 1 step 1).But the concentration of thrombin solution is 20U/ml.
Step 2) and 3) with the step 2 of example 1) and 3), the fibrin gel polylactic acid porous scaffold of filling.
Example 4:
Step 1) is with example 1 step 1).
Step 2) with the step 2 of example 1), but what adopt is the polylactic-co-glycolic acid porous support.
Step 3) gets the polylactic acid porous scaffold that fibrin gel is filled with example 1 step 3).
Example 5:
Step 1) is with example 1 step 1).
Step 2) with the step 2 of example 1), but what adopt is the polyurethane porous support.
Step 3) gets the polylactic acid porous scaffold that fibrin gel is filled with example 1 step 3).
Example 6:
Step 1) is with example 1 step 1).
Step 2) with the step 2 of example 1), but what adopt is the collagen porous support.
Step 3) gets the polylactic acid porous scaffold that fibrin gel is filled with example 1 step 3).
Example 7:
Step 1) and 2) with example 1 step 1) and 2).
Step 3) is with example 1 step 3), but incubation time is 5 minutes, gets the polylactic acid porous scaffold that fibrin gel is filled.
Example 8:
1) with the method preparation Fibrinogen and the thrombin solution of example 1 step 1), fibrinogenic concentration is respectively 10mg/ml, 20mg/ml and 40mg/ml, and the concentration of thrombin solution is 10U/ml.
2) isopyknic fibrinogen solution and thrombin solution are mixed, the gel time during utilized ultraviolet spectroscopy different fibrinogen concentration is seen Fig. 2.
Example 9:
1) prepares the Fibrinogen and the thrombin solution of various concentration with the method for example 8 step 1).
Step 2) and 3) with the step 2 of example 1) and 3).
4) utilize the method for weighing to calculate the filling rate of fibrin gel in polylactic acid bracket.Fig. 3 is the filling rate of the Fibrinogen filling polylactic acid support of variable concentrations (ultimate density behind the Fibrinogen gel).
Example 10:
1) step 1) is with example 1 step 1), but the concentration of fibrinogen solution is 40mg/ml, and the concentration of thrombin solution is 10U/ml.
Step 2) and 3) with example 1 step 2) and 3).Utilize the mechanical test instrument to measure the mechanical property of gel-free filling polylactic acid support and fibrin gel filling polylactic acid support, the results are shown in Figure 4, the mechanical strength of as seen filling after-poppet is improved.
Example 11:
Step 1) is with example 1 step 1), but the concentration of fibrinogen solution is 40mg/ml, and the concentration of thrombin solution is 10U/ml.Fibrinogen solution and thrombin solution are at first used 220nm filter membrane filtration sterilization.Then with chondrocyte and fibrinogen solution uniform mixing.The ultimate density of chondrocyte is 1,000,000/ml.
Step 2) and 3) with example 1 step 2) and 3).
The polylactic acid porous scaffold that the fibrin gel of preparation is filled is put in 24 well culture plates, adds culture fluid, carries out In vitro culture in incubator.Cytoactive adopts 3-(4, the 5-dimethylthiazole)-2, and 5-diphenyl tetrazole bromine salt (MTT) method detects.Fig. 5 is the variation of the activity of chondrocyte in the fibrin gel filling bracket with incubation time, and visible chondrocyte has higher activity in the support that fibrin gel is filled.Adopt 1, the method for the inferior blue chromogenic reagent-ultraviolet detection of 9-dimethyl is measured the mucoitin sulfuric acid (GAG) of emiocytosis, the results are shown in Figure 6, and visible chondrocyte can be secreted more GAG in the support that fibrin gel is filled.The form of cell culture after one week adopts laser confocal microscope and scanning electron microscope to observe, and the result sees Fig. 7 and Fig. 8 respectively.
Claims (2)
1. the preparation method of a polymer multihole bracket filled with fibrin gel, its step is as follows:
1) fibrinogen powder is dissolved in the normal saline, compound concentration is the fibrinogen solution of 10～40mg/ml; Thrombin is dissolved in the calcium chloride solution, and compound concentration is the thrombin calcium chloride solution of 1～20U/ml;
2) porous polymer scaffold is immersed in the ethanol, adopts first evacuation, the method for pressure is recovered in the back, and ethanol is imported in the porous polymer scaffold; To import alcoholic acid support and be immersed in the tri-distilled water, and carry out first evacuation repeatedly, the method for pressure is recovered in the back, and ethanol is replaced as water, and is residual until no ethanol;
3) solution with isopyknic fibrinogen solution and thrombin is injected in the porous polymer scaffold simultaneously, to prop up to be placed in 37 ℃ of constant temperature ovens and hatch 5～10 minutes, make the complete gel of Fibrinogen, promptly obtain polymer multihole bracket filled with fibrin gel.
2. by the preparation method of the described polymer multihole bracket filled with fibrin gel of claim 1, it is characterized in that said porous polymer scaffold is polylactic acid, polylactic-co-glycolic acid, polyurethane or collagen porous support.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710068119A CN101053679B (en) | 2007-04-17 | 2007-04-17 | Method for preparing polymer multiporous holder filled with fiber protein gel |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710068119A CN101053679B (en) | 2007-04-17 | 2007-04-17 | Method for preparing polymer multiporous holder filled with fiber protein gel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101053679A true CN101053679A (en) | 2007-10-17 |
| CN101053679B CN101053679B (en) | 2010-05-26 |
Family
ID=38793845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200710068119A Expired - Fee Related CN101053679B (en) | 2007-04-17 | 2007-04-17 | Method for preparing polymer multiporous holder filled with fiber protein gel |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101053679B (en) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102634978A (en) * | 2011-02-11 | 2012-08-15 | 傅亚 | Preparation method of fibrin glue reinforced polylactic acid fiber |
| CN101352581B (en) * | 2008-09-19 | 2012-09-26 | 中国人民解放军第三军医大学 | Adhesion agent for fixing articular cartilage repair implant and use of human fibrinogen in preparing the adhesion agent |
| WO2013039411A1 (en) * | 2011-09-12 | 2013-03-21 | Regionalne Centrum Krwiodawstwa I Krwiolecznictwa | Autologous and allogenic fibrin carrier, method of obtaining thereof and use of a fibrin carrier for transplantation of cells, particularly human cells |
| CN103372233A (en) * | 2012-04-13 | 2013-10-30 | 杭州龙禧生物医药科技有限公司 | Preparation method and product of tissue-engineered cartilage graft |
| RU2533457C1 (en) * | 2013-04-19 | 2014-11-20 | Федеральное государственное бюджетное учреждение "Федеральный научный центр трансплантации и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации | Bioactive resorbed porous 3d-matrix for regenerative medicine and method for preparing it |
| CN101716382B (en) * | 2009-12-02 | 2015-07-15 | 浙江大学 | Preparation method of trinary composite stent of plasmid DNA / fibrin gel / polymer |
| CN105107027A (en) * | 2015-07-17 | 2015-12-02 | 深圳爱生再生医学科技有限公司 | Fibrin gel-polylactic acid composite scaffold and preparation method thereof |
| CN105194731A (en) * | 2015-10-27 | 2015-12-30 | 上海科医联创生物科技有限公司 | Formula and preparation method for gel support used for in-vitro construction of tissue-engineered cartilage |
| CN106039420A (en) * | 2016-05-30 | 2016-10-26 | 浙江大学 | Fibrous protein material for cartilage and subchondral bone integral restoration and preparation method thereof |
| CN106620873A (en) * | 2016-11-17 | 2017-05-10 | 太原理工大学 | Composite hydrogel cartilage repair material and preparation method thereof |
| CN107715175A (en) * | 2017-09-30 | 2018-02-23 | 南京师范大学 | A kind of compound porous bone tissue engineering scaffold of PLGA/ amphions and preparation method thereof |
| CN108144127A (en) * | 2018-01-25 | 2018-06-12 | 南京医科大学附属口腔医院 | Fibrin gel/poly lactic-co-glycolic acid microsphere support and its preparation method and application |
| CN112656816A (en) * | 2021-01-15 | 2021-04-16 | 浙江大学 | Exosome-loaded fibrin glue and application thereof |
| CN114191615A (en) * | 2021-12-21 | 2022-03-18 | 浙江大学 | Multilayer composite material for promoting repair of articular cartilage-calcified layer-subchondral bone and preparation method thereof |
| CN114805917A (en) * | 2022-03-30 | 2022-07-29 | 浙江大学 | Preparation method of three-stage porous material based on fibrin fiber bridging |
| WO2023115295A1 (en) * | 2021-12-21 | 2023-06-29 | 浙江大学 | Multi-layer composite material for promoting articular cartilage-calcified layer-subchondral bone repair and preparation method therefor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5754800A (en) * | 1999-06-22 | 2001-01-09 | Brigham And Women's Hospital | Biologic replacement for fibrin clot for intra-articular use |
| EP1368419B1 (en) * | 2001-01-25 | 2005-11-16 | Nycomed Pharma AS | A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| CN1644221A (en) * | 2005-01-26 | 2005-07-27 | 徐小良 | Composite material for porous material and gel use thereof |
| CN2824875Y (en) * | 2005-04-14 | 2006-10-11 | 南方医院 | An injection type tissue engineering bone engraft |
| CN1928077A (en) * | 2006-09-28 | 2007-03-14 | 中国人民解放军军事医学科学院卫生装备研究所 | Cell three-dimensional culture method for tissue engineering |
-
2007
- 2007-04-17 CN CN200710068119A patent/CN101053679B/en not_active Expired - Fee Related
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101352581B (en) * | 2008-09-19 | 2012-09-26 | 中国人民解放军第三军医大学 | Adhesion agent for fixing articular cartilage repair implant and use of human fibrinogen in preparing the adhesion agent |
| CN101716382B (en) * | 2009-12-02 | 2015-07-15 | 浙江大学 | Preparation method of trinary composite stent of plasmid DNA / fibrin gel / polymer |
| CN102634978A (en) * | 2011-02-11 | 2012-08-15 | 傅亚 | Preparation method of fibrin glue reinforced polylactic acid fiber |
| WO2013039411A1 (en) * | 2011-09-12 | 2013-03-21 | Regionalne Centrum Krwiodawstwa I Krwiolecznictwa | Autologous and allogenic fibrin carrier, method of obtaining thereof and use of a fibrin carrier for transplantation of cells, particularly human cells |
| CN103372233A (en) * | 2012-04-13 | 2013-10-30 | 杭州龙禧生物医药科技有限公司 | Preparation method and product of tissue-engineered cartilage graft |
| RU2533457C1 (en) * | 2013-04-19 | 2014-11-20 | Федеральное государственное бюджетное учреждение "Федеральный научный центр трансплантации и искусственных органов имени академика В.И. Шумакова" Министерства здравоохранения Российской Федерации | Bioactive resorbed porous 3d-matrix for regenerative medicine and method for preparing it |
| CN105107027A (en) * | 2015-07-17 | 2015-12-02 | 深圳爱生再生医学科技有限公司 | Fibrin gel-polylactic acid composite scaffold and preparation method thereof |
| CN105194731A (en) * | 2015-10-27 | 2015-12-30 | 上海科医联创生物科技有限公司 | Formula and preparation method for gel support used for in-vitro construction of tissue-engineered cartilage |
| CN106039420A (en) * | 2016-05-30 | 2016-10-26 | 浙江大学 | Fibrous protein material for cartilage and subchondral bone integral restoration and preparation method thereof |
| CN106620873A (en) * | 2016-11-17 | 2017-05-10 | 太原理工大学 | Composite hydrogel cartilage repair material and preparation method thereof |
| CN107715175A (en) * | 2017-09-30 | 2018-02-23 | 南京师范大学 | A kind of compound porous bone tissue engineering scaffold of PLGA/ amphions and preparation method thereof |
| CN107715175B (en) * | 2017-09-30 | 2018-10-23 | 南京师范大学 | A kind of compound porous bone tissue engineering scaffold of PLGA/ amphoteric ions and preparation method thereof |
| CN108144127A (en) * | 2018-01-25 | 2018-06-12 | 南京医科大学附属口腔医院 | Fibrin gel/poly lactic-co-glycolic acid microsphere support and its preparation method and application |
| CN112656816A (en) * | 2021-01-15 | 2021-04-16 | 浙江大学 | Exosome-loaded fibrin glue and application thereof |
| CN114191615A (en) * | 2021-12-21 | 2022-03-18 | 浙江大学 | Multilayer composite material for promoting repair of articular cartilage-calcified layer-subchondral bone and preparation method thereof |
| CN114191615B (en) * | 2021-12-21 | 2022-07-08 | 浙江大学 | Multilayer composite material for promoting repair of articular cartilage-calcified layer-subchondral bone and preparation method thereof |
| WO2023115295A1 (en) * | 2021-12-21 | 2023-06-29 | 浙江大学 | Multi-layer composite material for promoting articular cartilage-calcified layer-subchondral bone repair and preparation method therefor |
| CN114805917A (en) * | 2022-03-30 | 2022-07-29 | 浙江大学 | Preparation method of three-stage porous material based on fibrin fiber bridging |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101053679B (en) | 2010-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101053679B (en) | Method for preparing polymer multiporous holder filled with fiber protein gel | |
| Wu et al. | Marginal sealing around integral bilayer scaffolds for repairing osteochondral defects based on photocurable silk hydrogels | |
| Li et al. | A chondroitin sulfate based injectable hydrogel for delivery of stem cells in cartilage regeneration | |
| CN102526806B (en) | Tissue engineering cartilage and preparation method thereof | |
| Li et al. | Biofabrication of a biomimetic supramolecular-polymer double network hydrogel for cartilage regeneration | |
| CN100594949C (en) | Method for producing compound frame of injection type polyester micro-carrier and fibrin gel | |
| CN106999635A (en) | Repair of cartilage graft support and its manufacture method | |
| CN109999227B (en) | Preparation method and application of silk fibroin and chitin-based blended nanofiber embedded hydrogel cartilage bionic scaffold | |
| CN101716382B (en) | Preparation method of trinary composite stent of plasmid DNA / fibrin gel / polymer | |
| CN103100112B (en) | Preparation method and use of graft material in double membrane structure | |
| CN112107731A (en) | Injectable double-layer drug-loaded osteochondral repair hydrogel scaffold and preparation method thereof | |
| CN107789668B (en) | Bionic collagen bone repair material with multilayer structure and preparation method thereof | |
| CN104667348B (en) | A kind of Pharmaceutical composition containing sodium alginate and preparation method thereof | |
| CN1837358A (en) | Method for expanding hemopoietic stem cell under three-dimensional condition | |
| CN110935067A (en) | Polyurethane/acellular fiber ring matrix fiber scaffold and preparation and application thereof | |
| CN108310463B (en) | 3D printing biological ink and preparation method thereof | |
| CN1609200A (en) | Prepn process of complicated tissue organ precursor | |
| CN1927416A (en) | Composite porous calcium phosphate bone cement and method for making same | |
| CN100462059C (en) | Method for preparing artificial skin used for reparing skin defect | |
| WO2023179544A1 (en) | 3d-printed bone defect repair scaffold loaded with mesenchymal stem cell extracellular matrixes and preparation method therefor | |
| CN1887359A (en) | Skin wound repairing agar/collagen dressing and its prepn and application | |
| Feng et al. | 3D printing of stem cell responsive ionically-crosslinked polyethylene glycol diacrylate/alginate composite hydrogels loaded with basic fibroblast growth factor for dental pulp tissue engineering: A preclinical evaluation in animal model | |
| Lucaciu et al. | Tissue engineered bone versus alloplastic commercial biomaterials in craniofacial reconstruction | |
| CN1562392A (en) | Method for fabricating activated artificial skin tissue in bilayer by using bioreactor | |
| CN113018517A (en) | 3D printing skin stent and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100526 Termination date: 20170417 |